National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria
Announcement of the spread of SARS-CoV-2 variants in the country 16 February 2022
The National Center for Infectious and Parasitic Diseases (NCIPD) reports that 679 clinical samples with SARS-CoV-2 collected from 17-30 January 2022 were analyzed by next-generation whole-genome sequencing. The clinical samples were collected in 44 different medical centers, from 24 districts of the country.
613 (90.3%) of the samples were defined as Omicron, 599 of which subvariant (ВА.1 or ВА.1.1) and 14 (BA.2). 66 (9.7%) of the samples were defined as Delta (B.1.617.2) or Delta subvariants (AY.*). Nextclade v1.13.1 and Pangolin COVID-19 Lineage Assigner v3.1.19 programs were used to define SARS-CoV-2 variants. An epidemiological analysis is being carried out.
For information on the classification of SARS-CoV-2 variants and sub-variants, please visit: https://cov-lineages.org/index.html
For an up-to-date classification of the variants of concern (VOC), please visit:
https://www.ecdc.europa.eu/en/covid-19/variants-concern
https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/
The NCIPD continues to monitor the spread of SARS-CoV-2 in the country, with a focus on VOC, altered virulence and immunogenicity that are of increased public health importance.